Advanced Chemistry Development

Overview

Advanced Chemistry Development, Inc. (ACD/Labs) is a Canadian company established in 1994, specializing in custom software and IT services within the business services sector. With an employee size ranging from 51 to 200, the company focuses on providing solutions for the biotech and pharmaceutical industries, particularly in drug discovery and development. ACD/Labs emphasizes the integration of artificial intelligence (AI) and digital technologies to enhance research and development processes. Their published white paper discusses the significance of AI-augmented innovation and the concept of a digital-physical convergence, which aims to streamline the drug discovery lifecycle by improving operational productivity, quality assurance, and regulatory compliance. The company advocates for the use of generative AI tools to optimize structure-activity relationships (SAR) in drug development, thereby facilitating the identification of effective drug candidates. Through these initiatives, ACD/Labs seeks to support organizations in bringing therapies to market more efficiently and safely, underscoring its commitment to advancing the pharmaceutical landscape.

Industry